SUMMARY
The main purpose of this study was to see if the offspring of surviving neuroblastoma, ganglioneuroblastoma, or ganglioneuroma patients have themselves a risk for developing tumours. No such risk was found. There was a total of 45 liveborn children who were all healthy. These children have passed through about 37 lifetimes of risk for developing neuroblastoma and about six lifetimes of risk for developing ganglioneuroma. No excess of cancers was found among parents and sibs.
It was interesting that there was a large female excess (35:12) among these survivors. One factor which may give rise to a better prognosis in females is the tendency of their tumours to mature to benign forms.
Neuroblastoma is a childhood tumour with a poor survival rate. Familial cases have been reported but these are rare. In 1972, Knudson and Strong' suggested that neuroblastoma was produced by two mutations, the first of which could be carried by a dominant gene. This suggestion was analogous to their hypothesis for the aetiology of retinoblastoma. The argument was based on observations that the rare familial cases of neuroblastoma have an earlier onset than the non-familial cases, with 56% being diagnosed during infancy compared to 26% of unselected, largely non-familial cases. Also, multiple tumours occur in only 5 % of unselected cases, but in nearly one-quarter of familial cases.
Since there has been an increase in the incidence of retinoblastoma2 following improved survival of patients, it was felt to be important to recognise whether the same could happen with neuroblastoma. The main aim of this study, therefore, was to observe whether the children of neuroblastoma patients who survived to adult life ran an increased risk of developing tumours.
Patients with a ganglioneuroblastoma or a ganglioneuroma were also included in the study. The proportion of neuroblastoma patients who have had children is small. The reason for this is not entirely clear, but some of the infertility may be the result of pelvic irradiation.
The present study does not reveal a risk that the offspring of neuroblastoma patients may themselves develop tumours. However, the numbers are small. To them may be added figures from a previous study by Li and Jaffe,23 in which there were seven adult females who had survived a neuroblastoma and three who had survived a ganglioneuroblastoma. These women had between them 18 liveborn children who had no evidence of neuroblastoma (although two premature babies died soon after birth). 
